Biracial women pushed to undergo genetic screeening: Cobble Hill hospital focuses on mixed race

Posted in Articles, Health/Medicine/Genetics, Media Archive, United States on 2013-01-14 17:32Z by Steven

Biracial women pushed to undergo genetic screeening: Cobble Hill hospital focuses on mixed race

New York Daily News
2013-01-13

Simone Weichselbaum

As interracial families become more common, LICH docs quiz women on ethnicity

Doctors are pushing biracial Brooklyn women to undergo genetic counseling to learn if their racial mix makes them more prone to disease.
 
As interracial families have beome more common, Dr. Millicent Comrie, Chief of Obstetrics and Gynecology at Downstate Long Island College Hospital, has urged her staff of about 40 physicians to quiz patients about their ethnic backgrounds.
 
Those from multicultural backgrounds are are sent to talk with a DNA expert who maps out how their heritage could make them sick.
 
“Ethnicity plays a big part in your healthcare,” said Comrie naming a slew of hereditary diseases such as sickle cell anemia which plagues the black community and Tay-Sachs disease found in many Jewish families.
 
“We can’t worry about sensitivity when it comes to race. What you see isn’t always what you get,” Comrie said. “If we don’t ask the right questions. We will come up We will come up short.”…

Read the entire article here.

Tags: , ,

Funding Race as Biology: The Relevance of “Race” in Medical Research

Posted in Articles, Health/Medicine/Genetics, Media Archive, Politics/Public Policy, United States on 2013-01-08 22:04Z by Steven

Funding Race as Biology: The Relevance of “Race” in Medical Research

Minnesota Journal of Law, Science & Technology
Volume 12, Issue 2 (Spring 2011)
pages 571-618

Taunya Lovell Banks, Jacob A. France Professor of Equality Jurisprudence and Francis & Harriet Iglehart Research Professor of Law
University of Maryland School of Law

Note from Steven F. Riley: See the articles, “Fracture Risk Assessment without Race/Ethnicity Information,” and “Taking race out of the equation in measuring women’s risk of osteoporosis and fractures” about the positive results of taking “race” out of medicine.

I. INTRODUCTION: ‘DEM BONES, ‘DEM BONES, ‘DEM “BLACK” BONES

In 1940 the State of North Carolina classified my friend as “colored” despite her “white skin, blue eyes, [and] curling blond hair.” She—like her parents, grandparents, and many other black Americans—is often mistaken for white. Sixty years later when she went for a bone densitometry test—a must for postmenopausal women—the technician asked her to fill out a form that asked her race. Surprised, she asked why. The technician explained that “since the bones of black people are different than the bones of white people, the doctor needed this information to interpret the scan correctly.”

The radiologist who analyzed my friend’s bone scan acknowledged that there is a debate within the radiology community about the scientific validity of interpreting an X-ray through the lens of race. But, he claimed, it is impossible to interpret the bone scan without factoring in race because the machines that analyze the bone scan can only produce an analysis if the race of the person being analyzed is included. The doctor could not explain how the x-ray machine defined “race,” replying that the definitions “were created by the companies that built the machines.”

My friend asked if there was any way she could get more helpful advice about the condition of her bones. The radiologist thought for a moment, then suggested that perhaps my friend should have her bone densitometry test performed twice, once as “white,” then as “black.” The condition of her bones, he told her, would lie somewhere between the two results. However, my friend concluded that “one-half of a fantasy definition of ‘white’ plus one-half of a fantasy definition of ‘black’ will only yield one whole fantasy: it will not provide a sound medical diagnosis.”  Thus she marked “black” or “African American” because that had always been her legal and social identity. So what did the results really tell her doctor?

For years my friend taught and wrote about the social construction of race and knew that her doctor’s explanation about the use of race as a biological term by the radiology community was flawed. She found it reminiscent of the World War II era when the Nazis kept “separate blood banks for ‘Jewish blood’ and ‘Aryan blood,’ [and] American blood banks were separating ‘white blood’ and ‘black blood’.” The United States has a long and continuing history of “unconscionable medical research” involving black Americans.

In 1950 the United Nations Educational, Scientific and Cultural Organization (UNESCO), mindful of race-science’s dark and not so distant history, drafted a statement on the use of race in modern science. This statement, developed by an esteemed group of anthropologists, psychologists, and sociologists, concludes: “[f]or all practical social purposes ‘race’ is not so much a biological phenomenon as a [damaging] social myth.” Today most scientists agree that race and ethnicity (ethno-race) classifications are the result of social and political conditions, as opposed to biological differences. There is, however, disagreement about the scientific validity of these categories.

Even though an increasing number of scientists believe that too often ethno-race is used as a surrogate for various socioeconomic and environmental factors, for most of the late twentieth century social science and medical researchers continued to use ethno-race in a biological context.

Nevertheless, there are times when ethno-racial designations have value in medical research. As one scholar writes, “using race as a social category” to study the impact of racism on health and access to medical care is critical to eliminating health inequities based on race. But, she cautions that using race as a biological category can reflect and reinforce racial stratification as well as racist notions of inherent human difference. Several commentators call this phenomenon the reification of race, where the social concept of race is transformed “into a specific, definite, concrete, and now presumably genetic category which can feed back into preexisting lay understandings of racial difference.”…

…This article proceeds from the assumption that there are few clear instances, other than perhaps access to health care or measuring equality in medical treatment, where the use of ethno-race in medical research is appropriate. Even in those limited situations the justification for using ethno-race, how the ethno-racial categories are defined, and the method for assigning ethno-race warrant close scrutiny and oversight, especially when these studies are funded with federal money. In the next section, this article explains the scientific basis for that assertion. First, it explores the debates within the medical community about the connection between race and biology in biomedicine. Then it examines literature on race-related stress to determine whether this might be an instance where ethno-racial labels help explain health outcomes, and argues that guidelines or regulation are needed.

The third section of this article examines two sets of guidelines on the use of ethno-race in biomedical research: guidelines adopted by high impact medical journals, and federal guidelines on the use of ethno-race in federally funded biomedical research. Finding these measures inadequate, this article argues that the only way to quickly change research behavior in this area is through greater regulation and oversight of federal medical research grants. More stringent government regulation and oversight of federally funded biomedical research grants that use ethno-race may trigger changes in the medical culture faster than litigation.

In the fourth section this article proposes a regulatory scheme that offers a standard to measure the appropriateness of ethno-race in applications for federally funded biomedical research that will cause both researchers and grant reviewers to give more thought to how and why ethno-race is used in research protocols. This article concedes that this proposal is only a first step, and acknowledges that meaningful progress also requires strong and effective measures designed to change how biology is taught in undergraduate, graduate, and professional schools. But without a change in the medical culture, another generation of researchers and health care providers will be trained to think about ethno-racial differences inappropriately.

Before effective remedies for the problem described can be discussed, it is important to clarify both the meaning and use of the term “race” in scientific discussions. The next section of this paper looks at debates within the scientific community about the meaning of ethno-racial labels…

Read the entire article here.

Tags: , , ,

From Bang to Whimper: A Heart Drug’s Story

Posted in Articles, Book/Video Reviews, Health/Medicine/Genetics, Media Archive, United States on 2013-01-08 16:33Z by Steven

From Bang to Whimper: A Heart Drug’s Story

The New York Times
2012-12-24

Abigail Zuger, M.D.

Jonathan Kahn, Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age. Columbia University Press, December 2012, 336 pages.

On June 23, 2005, American medicine managed to take a small step forward and a giant step backward at precisely the same time, with government approval of the first medication to be earmarked for a specific racial group. It was BiDil, a drug designed to treat heart failure in blacks.

Enthusiasts hailed BiDil’s approval by the Food and Drug Administration as a landmark event in the nascent field of pharmacogenomics, which aims to create drugs tailored to fit an individual’s genetic makeup as precisely as a bespoke suit drapes its owner’s shoulders. Critics just winced and clocked one more misstep in medicine’s long history of race-related disasters.

You would think that the elucidation of the human genome would have cleared up most of the hoary untruths surrounding race and health. But as Jonathan Kahn makes clear in his worthy if convoluted review of the events surrounding the birth of BiDil, the genome has in many respects only made things worse.

It has been clear for decades that race has minimal relevance to the body’s inner workings. Research has repeatedly shown that the biologic variations among individuals of the same race are reliably great enough for race to retain little utility as a biologic predictor. You might as well sort people by height. Or, in the words of an editorial writer for Nature Biotechnology in 2005, “Pooling people in race silos is akin to zoologists grouping raccoons, tigers and okapis on the basis that they are all stripy.”

Read the entire review here.

Tags: , , , ,

How Personalized Medicine Became Genetic, and Racial: Werner Kalow and the Formations of Pharmacogenetics

Posted in Articles, Health/Medicine/Genetics, Media Archive on 2012-12-25 20:44Z by Steven

How Personalized Medicine Became Genetic, and Racial: Werner Kalow and the Formations of Pharmacogenetics

Journal of the History of Medicine and Allied Sciences
Volume 68, Number 1, January 2013
pages 1-48
DOI: 10.1093/jhmas/jrr046

David S. Jones, A. Bernard Ackerman Professor of the Culture of Medicine
Harvard University

Physicians have long puzzled over a well-known phenomenon: different patients respond differently to the same treatment. Although many explanations exist, pharmacogenetics has now captured the medical imagination. While this might seem part of the broader interest in all things genetic, the early history of pharmacogenetics reveals the specific factors that contributed to the emergence of genetics within pharmacology. This paper examines the work of one pioneering pharmacologist, Werner Kalow, to trace the evolving intellectual formations of pharmacogenetics and, in particular, the focus on race. Working in the 1950s and 1960s, Kalow made three arguments to demonstrate the relevance of genetics to pharmacology, based on laboratory techniques, analogies to differences between other animal species, and appeals to the logic of natural selection. After contributing to the emergence of the field, Kalow maintained his advocacy for pharmacogenetics for four decades, collecting more evidence for its relevance, navigating controversies about race and science, and balancing genetics against other possible explanations of patient variability. Kalow’s work demonstrates the deep roots of the genetic and racial preoccupations in pharmacology. Understanding this history can restore attention to other explanations of individuality in medical practice, something of increasing importance given the current interest in personalized medicine.

Read the entire article here.

Tags: , , ,

Medicating Race: Heart Disease and Durable Preoccupations with Difference

Posted in Books, Health/Medicine/Genetics, Media Archive, Monographs, Politics/Public Policy, United States on 2012-12-22 19:05Z by Steven

Medicating Race: Heart Disease and Durable Preoccupations with Difference

Duke University Press
October 2012
280 pages
5 illustrations
Paperback ISBN: 978-0-8223-5344-7
Cloth ISBN: 978-0-8223-5329-4

Anne Pollock, Assistant Professor of Science, Technology and Culture
Georgia Institute of Technology, Atlanta, Georgia

In Medicating Race, Anne Pollock traces the intersecting discourses of race, pharmaceuticals, and heart disease in the United States over the past century, from the founding of cardiology through the FDA’s approval of BiDil, the first drug sanctioned for use in a specific race. She examines wide-ranging aspects of the dynamic interplay of race and heart disease: articulations, among the founders of American cardiology, of heart disease as a modern, and therefore white, illness; constructions of “normal” populations in epidemiological research, including the influential Framingham Heart Study; debates about the distinctiveness African American hypertension, which turn on disparate yet intersecting arguments about genetic legacies of slavery and the comparative efficacy of generic drugs; and physician advocacy for the urgent needs of black patients on professional, scientific, and social justice grounds. Ultimately, Pollock insists that those grappling with the meaning of racialized medical technologies must consider not only the troubled history of race and biomedicine but also its fraught yet vital present. Medical treatment should be seen as a site of, rather than an alternative to, political and social contestation. The aim of scholarly analysis should not be to settle matters of race and genetics, but to hold medicine more broadly accountable to truth and justice.

Table of Contents

  • Acknowledgments
  • Introduction
  • 1. Racial Preoccupations and Early Cardiology
  • 2. Making Normal Populations and Making Difference in the Framingham and Jackson Heart Studies
  • 3. The Durability of African American Hypertension as a Disease Category
  • 4. The Slavery Hypothesis beyond Genetic Determinism
  • 5. Thiazide Diuretics as a Nexus of Associations: Racialized, Proven, Old, Cheap
  • 6. BiDil: Medicating the Intersection of Race and Heart Failure
  • Conclusion
  • Notes
  • Works Cited
  • Index
Tags: , ,

The Chalk Circle: Intercultural Prizewinning Essays

Posted in Anthologies, Anthropology, Asian Diaspora, Autobiography, Books, Health/Medicine/Genetics, Media Archive, Native Americans/First Nation, Religion on 2012-12-21 05:01Z by Steven

The Chalk Circle: Intercultural Prizewinning Essays

Wyatt-MacKenzie Publishing
2012-05-15
220 pages
5 x 8
Paperback ISBN: 978-1-936214-71-6

Tara L. Masih, Writer & Editor

Award-winning editor Tara L. Masih put out a call in 2007 for Intercultural Essays dealing with the subjects of “culture, race, and a sense of place.” The prizewinners are gathered for the first time in a ground-breaking anthology that explores many facets of culture not previously found under one cover. The powerful, honest, thoughtful voices—Native American, African American, Asian, European, Jewish, White—speak daringly on topics not often discussed in the open, on subjects such as racism, anti-Semitism, war, self-identity, gender, societal expectations. Their words will entertain, illuminate, take you to distant lands, and spark important discussions about our humanity, our culture, and our place within society and the natural world.

  • Winner of a 2012 Skipping Stones Honor Award
  • A Featured NewPages.com New & Noteworthy Book, February 2012
  • An Amazon Hot New Release, debuting at #2 on the essay bestseller list

Table of Contents

  • Foreword by Tara L. Masih
  • Introduction by David Mura
  • THE CHALK CIRCLE: IDENTITY, HOME, AND BORDERLANDS
    • If Grandmother Had Married a Peasant Li Miao Lovett
    • Fragments: Finding Center Sarah J. Stoner
    • Giiwe: go home Christine Stark
  • AS I AM: LETTERS OF IDENTITY
    • Bufferhood: An Autoethnography Emma Sartwell
    • Valentine and This Difficult World Tilia Klebenov Jacobs
  • THE TONGUE OF WAR: A CLASH OF CULTURES
    • Reflecting on Dragons and Angels Shanti Elke Bannwart
    • Tongue-Tied Kelly Hayes-Raitt
    • Tightrope Across the Abyss Shanti Elke Bannwart
  • THE TRAGEDY OF THE COLOR LINE
    • A Dash of Pepper in the Snow Samuel Autman
    • “Miss Otis Regrets” Mary Elizabeth Parker
    • Signatures Lyzette Wanzer
  • EYEWITNESS: AS SEEN BY ANOTHER
    • Winter Seagull Toshi Washizu
    • Itam Jeff Fearnside
    • High Tech in Gaborone M. Garrett Bauman
    • Triptych: Paradise Gretchen Brown Wright
  • THE OTHER
    • Assailing Otherness Katrina Grigg-Saito
    • Fried Locusts Kamela Jordan
    • Israel: Devour the Darling Plagues Bonnie J. Morris
  • THE CULTURE OF SELF AND SPIRIT
    • Connections Betty Jo Goddard
    • Palo del Muerte Simmons B. Buntin
  • QUESTIONS FOR DISCUSSION
    • Intercultural Considerations
    • Intercultural Connections
    • Quotation Exploration
  • About the Editor, Tara L. Masih
  • Acknowledgments
  • About the Introduction Author, David Mura
  • Index of Contributors
Tags: , , , , , , , , , , , , , , , , , , , , , ,

Demographic, residential, and socioeconomic effects on the distribution of nineteenth-century African-American stature

Posted in Articles, Economics, Health/Medicine/Genetics, History, Media Archive, United States on 2012-12-16 05:59Z by Steven

Demographic, residential, and socioeconomic effects on the distribution of nineteenth-century African-American stature

Journal of Population Economics
Volume 24, Issue 4 (October 2011)
pages 1471-1491
DOI: 10.1007/s00148-010-0324-x

Scott Alan Carson, Professor of Economics
The University of Texas of the Permian Basin

Nineteenth-century mulattos were taller than their darker-colored African-American counterparts. However, traditional explanations that attribute the mulatto stature advantage to only socioeconomic factors are yet to tie taller mulatto statures to observable phenomenon. Vitamin D production may also explain part of the nineteenth-century mulatto–black stature differential. Mulattos were taller than darker-pigmented blacks across the stature distribution, and higher melanin concentrations in darker black stratum corneums reduced the amount of vitamin D synthesized. The interaction with sunlight in darker-complexioned blacks was associated with larger stature returns for darker-complexioned blacks than their mulatto counterparts.

Read the entire article here.

Tags: , , ,

Association of Contextual Factors with Drug Use and Binge Drinking among White, Native American, and Mixed-Race Adolescents in the General Population

Posted in Articles, Health/Medicine/Genetics, Media Archive, Native Americans/First Nation, Social Work, United States on 2012-12-16 05:14Z by Steven

Association of Contextual Factors with Drug Use and Binge Drinking among White, Native American, and Mixed-Race Adolescents in the General Population

Journal of Youth and Adolescence
Volume 41, Issue 11 (November 2012)
pages 1426-1441
DOI: 10.1007/s10964-012-9789-0

Hsing-Jung Chen
Department of Social Work
Fu-Jen Catholic University, New Taipei City, Taiwan

Sundari Balan, Postdoctoral Research Associate
Department of Psychiatry
Washington University in St. Louis

Rumi Kato Price, Research Professor
Department of Psychiatry
Washington University in St. Louis

Large-scale surveys have shown elevated risk for many indicators of substance abuse among Native American and Mixed-Race adolescents compared to other minority groups in the United States. This study examined underlying contextual factors associated with substance abuse among a nationally representative sample of White, Native American, and Mixed-Race adolescents 12–17 years of age, using combined datasets from the National Survey on Drug Use and Health (NSDUH 2006–2009, N = 46,675, 48.77% female). Native American adolescents displayed the highest rate of past-month binge drinking and past-year illicit drug use (14.06 and 30.91%, respectively). Results of a logistic regression that included seven predictors of social bonding, individual views of substance use, and delinquent peer affiliations showed that friendships with delinquent peers and negative views of substance use were associated significantly with both substance abuse outcomes among White and Mixed-Race adolescents and, to a lesser extent, Native American adolescents. The association of parental disapproval with binge drinking was stronger for White than for Native American adolescents. Greater attention to specific measures reflecting racial groups’ contextual and historical differences may be needed to delineate mechanisms that discourage substance abuse among at-risk minority adolescent populations.

Read the entire article here.

Tags: , , ,

Dismantling the Race Myth

Posted in Anthropology, Asian Diaspora, Forthcoming Media, Health/Medicine/Genetics, History, Identity Development/Psychology, Law, Literary/Artistic Criticism, Live Events, Politics/Public Policy, United States on 2012-12-07 16:20Z by Steven

Dismantling the Race Myth

Kyoto International Conference Center
Kyoto, Japan
2012-12-15 through 2012-12-16


Poster (PDF, Japanese)

Institute for Research in Humanities, Kyoto University presents International Symposium.
 
“Race” still has social reality even though it has no biological reality. This symposium aims to dismantle the race myth by bringing together scholars in a wide range of disciplines from Japan and abroad. While race studies have hitherto been confined to trans-Atlantic experiences, we will shed lights on “invisibility,” “ambiguity,” and “in-between-ness” with special reference to Japanese and Asian experiences.

Schedule

  • Saturday, December 15, 2012
    • Part I. Invisibility: Representation of Invisible Race
      • Takashi Fujitani (Toronto University) / Appearances Can Be Deceiving: Tennosei, Global Modernity, and the Anxieties of Ocular-centric Racism
      • Ayako Saito (Meiji Gakuin University) / Note on the Film Representation of the “Hisabetsu Burakumin”
      • Joong-Seop Kim (Gyeongsang National University) / The Formation of an Invisible Race: the case of the Korean “Paekjong”
      • Ariela Gross (University of Southern California) / Laws of Blood: The Science and Performance of Race in U.S. Courtrooms
      • Relay Talk and Poster Session by Junior Researchers
      • Social Hour
  • Sunday, December 16, 2012
    • Part II. Knowledge: Co-production of Science and Society
      • Arnaud Nanta (Centre National de la Recherche Scientifique) / Critique on the Idea of “Race” in French Anthropology, 1930s-1940s
      • Wataru Kusaka (Kyoto University) / American Colonial Public Health and the Leprosy Patients’ Revolt: Discipline and Desire on Culion Island, Philippines
      • Miho Ishii (Kyoto University) / Blood, Gifts, and “Community” in India: Betwixt and Between Marking and Anonymisation
      • Yasuko Takezawa (Kyoto University), Kazuto Kato (Osaka University), Hiroki Oota (Kitazato University) / Population Descriptors in Genetic Studies and Biomedicine
    • Part III. Hybridity: Beyond the Politics of “Blood”
      • Ryuichi Narita (Japan Women’s University) / Politics of “Mixed Race” in Modern Japan
      • Mika Ko (Rikkyo University) / Cinematic Representations of “Mixed-Race” People in 1930s Japanese Cinema: The Two Faces of Japan’s Modernity
      • Masako Kudo (Kyoto Women’s University) / Border-crossing and Identity Construction by Children of Japanese-Pakistani Marriage
      • Duncan Williams (University of Southern California) / Japan and Its Global Mixed Race History

This is part of a joint research project, a Japan-based Global Study of Racial Representations with Grants-in-Aid for Scientific Research (S). The organizers are grateful to Japan Society for the Promotion of Science for its sponsorship of this event. We are also thankful to Science Council of Japan for their support.

For more information, click here.

Tags: , , , , , , , , , , , , , , ,

Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age

Posted in Books, Health/Medicine/Genetics, Media Archive, Monographs, Politics/Public Policy, United States on 2012-12-07 05:18Z by Steven

Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age

Columbia University Press
December, 2012
336 pages
Charts: 4, B&W Illus.: 1
Cloth ISBN: 978-0-231-16298-2

Jonathan Kahn, Professor of Law
Hamline University, Saint Paul, Minnesota

At a ceremony announcing the completion of the first draft of the human genome in 2000, President Bill Clinton declared, “I believe one of the great truths to emerge from this triumphant expedition inside the human genome is that in genetic terms, all human beings, regardless of race, are more than 99.9 percent the same.” Yet despite this declaration of unity, biomedical research has focused increasingly on mapping that .1 percent of difference, particularly as it relates to race.

This trend is exemplified by the drug BiDil. Approved by the FDA in 2005 as the first drug with a race-specific indication on its label, BiDil was originally touted as a pathbreaking therapy to treat heart failure in black patients and help underserved populations. Upon closer examination, however, Jonathan Kahn reveals a far more complex story. At the most basic level, BiDil became racial through legal maneuvering and commercial pressure as much as through medical understandings of how the drug worked. Using BiDil as a central case study, Kahn broadly examines the legal and commercial imperatives driving the expanding role of race in biomedicine, even as scientific advances in genomics could render the issue irrelevant. He surveys the distinct politics informing the use of race in medicine and the very real health disparities caused by racism and social injustice that are now being cast as a mere function of genetic difference. Calling for a more reasoned approach to using race in biomedical research and practice, Kahn asks readers to recognize that, just as genetics is a complex field requiring sensitivity and expertise, so too is race, particularly in the field of biomedicine.

Contents

  • Acknowledgments
  • INTRODUCTION: Race and Medicine: Framing [Is] the Problem
  • 1. ORGANIZING RACE: Paths Toward the Re-Biologization of Race in Modern Biomedical Research, Practice, and Product Development
  • 2. THE BIRTH OF BIDIL: How a Drug Becomes “Ethnic”
  • 3. STATISTICAL MISCHIEF AND RACIAL FRAMES FOR DRUG DEVELOPMENT AND MARKETING
  • 4. CAPITALIZING [ON] RACE IN DRUG DEVELOPMENT
  • 5. RACE-ING PATENTS/PATENTING RACE: An Emerging Political Geography of Intellectual Property in Biotechnology
  • 6. NOT FADE AWAY: The Persistence of Race and the Politics of the “Meantime” in Pharmacogenomics
  • 7. FROM DISPARITY TO DIFFERENCE: The Politics of Racial Medicine
  • CONCLUSIONS AND RECOMMENDATIONS
  • Notes
  • Index
Tags: , ,